Advisors Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.73M Sell
79,806
-46,129
-37% -$3.55M 0.1% 294
2025
Q4
$9.99M Sell
125,935
-54,104
-30% -$4.27M 0.17% 137
2025
Q3
$13.5M Sell
180,039
-9,690
-5% -$664K 0.23% 77
2025
Q2
$13.1M Sell
189,729
-1,630
-0.9% -$107K 0.23% 75
2025
Q1
$13M Buy
191,359
+2,151
+1% +$129K 0.24% 74
2024
Q4
$8.49M Buy
189,208
+55,542
+42% +$3.12M 0.16% 148
2024
Q3
$8.4M Buy
133,666
+34,728
+35% +$2.03M 0.15% 160
2024
Q2
$5.84M Sell
98,938
-7,698
-7% -$482K 0.11% 224
2024
Q1
$8.51M Sell
106,636
-1,019
-0.9% -$77.8K 0.16% 150
2023
Q4
$8.5M Sell
107,655
-11,783
-10% -$839K 0.17% 129
2023
Q3
$8.34M Sell
119,438
-14,417
-11% -$1.02M 0.18% 121
2023
Q2
$9.25M Sell
133,855
-15,319
-10% -$1.09M 0.19% 114
2023
Q1
$11.1M Sell
149,174
-7,771
-5% -$652K 0.23% 90
2022
Q4
$14.6M Sell
156,945
-9,629
-6% -$929K 0.3% 63
2022
Q3
$15.9M Sell
166,574
-25,604
-13% -$2.53M 0.33% 56
2022
Q2
$17.8M Sell
192,178
-8,518
-4% -$831K 0.34% 57
2022
Q1
$20.3M Sell
200,696
-10,638
-5% -$1.12M 0.31% 57
2021
Q4
$21.8M Sell
211,334
-5,156
-2% -$476K 0.31% 57
2021
Q3
$18.4M Sell
216,490
-8,610
-4% -$721K 0.28% 65
2021
Q2
$18.8M Buy
225,100
+2,707
+1% +$222K 0.28% 63
2021
Q1
$16.7M Sell
222,393
-7,052
-3% -$514K 0.26% 69
2020
Q4
$15.7M Sell
229,445
-219
-0.1% -$14.2K 0.26% 68
2020
Q3
$13.4M Sell
229,664
-31,454
-12% -$1.96M 0.25% 71
2020
Q2
$17M Sell
261,118
-43,362
-14% -$2.73M 0.33% 54
2020
Q1
$18.1M Buy
304,480
+16,466
+6% +$1.1M 0.43% 38
2019
Q4
$21.4M Buy
288,014
+21,256
+8% +$1.49M 0.38% 47
2019
Q3
$16.8M Buy
266,758
+51,046
+24% +$3.02M 0.31% 68
2019
Q2
$11.8M Buy
215,712
+75,762
+54% +$4.08M 0.21% 99
2019
Q1
$7.55M Buy
139,950
+32,773
+31% +$2.02M 0.13% 176
2018
Q4
$7.02M Sell
107,177
-15,776
-13% -$1.18M 0.14% 171
2018
Q3
$9.68M Sell
122,953
-31,172
-20% -$2.23M 0.16% 154
2018
Q2
$9.92M Sell
154,125
-29,985
-16% -$1.98M 0.17% 149
2018
Q1
$12.5M Sell
184,110
-30,268
-14% -$2.17M 0.21% 113
2017
Q4
$15.5M Buy
214,378
+11,639
+6% +$846K 0.26% 91
2017
Q3
$16.5M Buy
202,739
+3,545
+2% +$280K 0.28% 85
2017
Q2
$16M Buy
199,194
+15,979
+9% +$1.26M 0.27% 86
2017
Q1
$14.4M Sell
183,215
-1,109
-0.6% -$88.5K 0.24% 101
2016
Q4
$14.5M Sell
184,324
-523
-0.3% -$42.3K 0.24% 94
2016
Q3
$16.4M Sell
184,847
-16,054
-8% -$1.52M 0.27% 84
2016
Q2
$19.2M Buy
+200,901
New +$20M 0.31% 60
2016
Q1
Sell
-176,949
Closed -$17.3M 1843
2015
Q4
$17.3M Buy
176,949
+61,535
+53% +$6.03M 0.27% 81
2015
Q3
$11.1M Buy
115,414
+29,170
+34% +$3.07M 0.18% 150
2015
Q2
$9.04M Buy
86,244
+4,579
+6% +$468K 0.12% 227
2015
Q1
$8.43M Sell
81,665
-11,722
-13% -$1.19M 0.11% 234
2014
Q4
$8.99M Buy
93,387
+10,342
+12% +$911K 0.12% 219
2014
Q3
$6.61M Sell
83,045
-1,927
-2% -$152K 0.09% 283
2014
Q2
$6.4M Buy
84,972
+739
+0.9% +$55.9K 0.09% 278
2014
Q1
$6.31M Buy
84,233
+1,290
+2% +$91.1K 0.1% 267
2013
Q4
$5.94M Buy
82,943
+5,037
+6% +$324K 0.1% 277
2013
Q3
$4.42M Buy
77,906
+17,073
+28% +$1.02M 0.08% 315
2013
Q2
$3.48M Buy
+60,833
New +$3.52M 0.07% 353

Other funds holding CVS

Advisors Asset Management's CVS Position: Q1 2026 in Review

Advisors Asset Management reduced its CVS Health (CVS) stake by 37% in Q1 2026, selling an estimated $3.55M and leaving 79,806 shares worth $5.73M. The position accounts for 0.1% of the portfolio, ranked #294.

Advisors Asset Management first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $21.8M in Q4 2021. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Advisors Asset Management held 79,806 shares of CVS Health worth $5.73M as of Q1 2026.
  • Advisors Asset Management sold 46,129 CVS Health shares in Q1 2026, an estimated $3.55M.
  • CVS Health made up 0.1% of Advisors Asset Management's portfolio in Q1 2026, its #294 holding.
  • Advisors Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Advisors Asset Management's CVS Health position peaked at $21.8M in Q4 2021.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Advisors Asset Management's 13F filing for Q1 2026, filed 15 May 2026.